News Event
New Lung Cancer Treatment- Medindia
Posted Date: 1/4/2011 3:46:00 PM

Researchers at Harvard Medical School and the Massachusetts General Hospital in Boston, Massachusetts are developing a new lung cancer drug for Pfizer. Currently in the early phases of a stage 3 clinical trial, Crizotinib was successful in shrinking non-small cell lung cancer tumors by at least 30% in 47 of 82 patients exhibiting cancers with a specific mutation in the anaplastic lymphoma kinase gene. Tumor growth halted in another 27 patients in the study, meaning that 90% of (the admittedly small) test base showed at least some benefit from taking the drug.

Follow medcarpet on Twitter Facebook: medcarpet
  Job Seeker Login

  Employer Zone

  Post Resume - FREE
Fields marked * are mandatory.
*Upload Resume / CV

Word or Text file upto 350 KB.

*Your Email ID

  I accept Terms of Use and Privacy Policy
  Job Seeker Services
  Get jobs in your inbox
Set your own criteria to receive relevant jobs in your inbox without registering on Medcarpet.
Create a new Job Alert
  News & Events
FDA Approves new Obesity Drug- Locraserin ...
Efforts being made to strenghten Medical Education ...

click for more »